SHELLEY WATCHAM

Associate Medical Director, UK and Ireland

Sobi

Dr Shelley Watcham is Associate Medical Director for UK and Ireland at Swedish Orphan Biovitrum (Sobi), a small biopharmaceutical company specialising in treatments for rare diseases. After an undergraduate degree in human genetics, Shelley trained in medicine and practiced for five years before moving into the pharmaceutical industry. Her career in the pharmaceutical industry started in regulatory affairs submitting clinical trial applications to regulators, before moving into medical affairs. In her current role Shelley’s team provide medical support for products indicated in several rare immunological and metabolic diseases.